nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYSLTR2—cardiovascular system—attention deficit hyperactivity disorder	0.0575	0.327	CbGeAlD
Zafirlukast—CYSLTR1—nervous system—attention deficit hyperactivity disorder	0.0139	0.079	CbGeAlD
Zafirlukast—CYSLTR1—central nervous system—attention deficit hyperactivity disorder	0.0134	0.076	CbGeAlD
Zafirlukast—CYSLTR1—brain—attention deficit hyperactivity disorder	0.0106	0.0604	CbGeAlD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00729	0.00885	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0072	0.00874	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00718	0.00871	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00718	0.00871	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0071	0.00861	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00671	0.00814	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00667	0.00809	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00654	0.00793	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00635	0.0077	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00628	0.00762	CbGpPWpGaD
Zafirlukast—PTGS1—forebrain—attention deficit hyperactivity disorder	0.00622	0.0354	CbGeAlD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0062	0.00752	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00618	0.00749	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.006	0.00729	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00598	0.00725	CbGpPWpGaD
Zafirlukast—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00597	0.00724	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0059	0.00716	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00585	0.0071	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00584	0.00708	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00583	0.00707	CbGpPWpGaD
Zafirlukast—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00576	0.0327	CbGeAlD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00571	0.00693	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00565	0.00686	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00561	0.00681	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00555	0.00674	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00549	0.00666	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00549	0.00666	CbGpPWpGaD
Zafirlukast—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00546	0.031	CbGeAlD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00543	0.00659	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00543	0.00659	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00532	0.00645	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00531	0.00645	CbGpPWpGaD
Zafirlukast—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00526	0.0299	CbGeAlD
Zafirlukast—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00519	0.0063	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00514	0.00624	CbGpPWpGaD
Zafirlukast—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00511	0.0291	CbGeAlD
Zafirlukast—CYSLTR2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00511	0.0062	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00506	0.00614	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00499	0.00606	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00498	0.00604	CbGpPWpGaD
Zafirlukast—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00492	0.028	CbGeAlD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00492	0.00597	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00478	0.0058	CbGpPWpGaD
Zafirlukast—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00478	0.0058	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0047	0.0057	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00465	0.00565	CbGpPWpGaD
Zafirlukast—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00461	0.00559	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0044	0.00534	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00435	0.00528	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00414	0.00503	CbGpPWpGaD
Zafirlukast—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00408	0.00495	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00406	0.00492	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00406	0.00492	CbGpPWpGaD
Zafirlukast—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00405	0.00491	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00404	0.00491	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00392	0.00475	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00385	0.00467	CbGpPWpGaD
Zafirlukast—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00381	0.0217	CbGeAlD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0038	0.00461	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0038	0.00461	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00376	0.00456	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00373	0.00453	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00369	0.00447	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00369	0.00447	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00358	0.00434	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00357	0.00433	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00355	0.0043	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00354	0.0043	CbGpPWpGaD
Zafirlukast—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.0035	0.0199	CbGeAlD
Zafirlukast—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00338	0.0192	CbGeAlD
Zafirlukast—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00337	0.0192	CbGeAlD
Zafirlukast—CYSLTR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00331	0.00402	CbGpPWpGaD
Zafirlukast—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.0033	0.0187	CbGeAlD
Zafirlukast—CYSLTR2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0033	0.004	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00326	0.00395	CbGpPWpGaD
Zafirlukast—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00325	0.0185	CbGeAlD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00322	0.00391	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00321	0.00389	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00319	0.00388	CbGpPWpGaD
Zafirlukast—CYP2C8—brain—attention deficit hyperactivity disorder	0.00318	0.0181	CbGeAlD
Zafirlukast—CYSLTR2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00314	0.00381	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00314	0.00381	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0031	0.00376	CbGpPWpGaD
Zafirlukast—ABCG2—brain—attention deficit hyperactivity disorder	0.00309	0.0176	CbGeAlD
Zafirlukast—CYSLTR2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00308	0.00374	CbGpPWpGaD
Zafirlukast—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00305	0.0037	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00299	0.00363	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0029	0.00352	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00289	0.0035	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00285	0.00346	CbGpPWpGaD
Zafirlukast—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00282	0.016	CbGeAlD
Zafirlukast—CYSLTR2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00282	0.00342	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00281	0.00341	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00281	0.0034	CbGpPWpGaD
Zafirlukast—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00277	0.0158	CbGeAlD
Zafirlukast—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00271	0.0154	CbGeAlD
Zafirlukast—CYP2E1—brain—attention deficit hyperactivity disorder	0.00268	0.0152	CbGeAlD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00268	0.00325	CbGpPWpGaD
Zafirlukast—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00267	0.0152	CbGeAlD
Zafirlukast—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00264	0.0032	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00262	0.00318	CbGpPWpGaD
Zafirlukast—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00261	0.0148	CbGeAlD
Zafirlukast—CYSLTR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00259	0.00314	CbGpPWpGaD
Zafirlukast—PTGS1—brain—attention deficit hyperactivity disorder	0.00258	0.0147	CbGeAlD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00255	0.0031	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00248	0.00301	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00246	0.00298	CbGpPWpGaD
Zafirlukast—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00235	0.00286	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00229	0.00277	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00223	0.00271	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00222	0.0027	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00221	0.00269	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00218	0.00265	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00218	0.00264	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00218	0.00264	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00218	0.00264	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00217	0.00263	CbGpPWpGaD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00216	0.00263	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00215	0.00261	CbGpPWpGaD
Zafirlukast—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00215	0.0026	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00213	0.00259	CbGpPWpGaD
Zafirlukast—CYP2D6—brain—attention deficit hyperactivity disorder	0.00212	0.0121	CbGeAlD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.0021	0.00255	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00208	0.00252	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00202	0.00245	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00201	0.00244	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.002	0.00243	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00198	0.0024	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00195	0.00237	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.0019	0.00231	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00184	0.00223	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00183	0.00223	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00182	0.00221	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00177	0.00215	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00171	0.00208	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00168	0.00204	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00168	0.00204	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00166	0.00202	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00163	0.00198	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00162	0.00197	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00161	0.00195	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00155	0.00188	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00151	0.00183	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00142	0.00172	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00141	0.00171	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.0014	0.0017	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0014	0.0017	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00139	0.00169	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00132	0.0016	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00127	0.00155	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00126	0.00153	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00125	0.00152	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00124	0.00151	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00123	0.00149	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00121	0.00147	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00121	0.00147	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00119	0.00144	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00142	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00116	0.00141	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00115	0.00139	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00114	0.00139	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00114	0.00138	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00113	0.00137	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00109	0.00132	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00107	0.0013	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000981	0.00119	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000976	0.00118	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000974	0.00118	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000968	0.00117	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00093	0.00113	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000893	0.00108	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000757	0.000919	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000752	0.000913	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000752	0.000912	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000747	0.000906	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000667	0.00081	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000642	0.000779	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000642	0.000779	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000631	0.000766	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000616	0.000748	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000616	0.000748	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000606	0.000736	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000587	0.000712	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000577	0.0007	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000575	0.000698	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000564	0.000684	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000515	0.000625	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000513	0.000622	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000493	0.000598	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000488	0.000593	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000474	0.000575	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00047	0.00057	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000469	0.000569	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000461	0.000559	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000461	0.000559	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000453	0.00055	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000421	0.000511	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000401	0.000487	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000399	0.000484	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000398	0.000483	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000398	0.000483	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000392	0.000475	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000389	0.000472	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000386	0.000468	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000373	0.000453	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000371	0.00045	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000368	0.000447	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000364	0.000442	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00036	0.000436	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000355	0.000431	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000355	0.000431	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000351	0.000425	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00035	0.000424	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000327	0.000397	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000327	0.000397	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000325	0.000394	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000324	0.000393	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000324	0.000393	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000322	0.00039	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000319	0.000387	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000318	0.000386	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00031	0.000376	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000303	0.000368	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000299	0.000363	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000296	0.00036	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000284	0.000345	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000279	0.000339	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000277	0.000336	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000277	0.000336	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000277	0.000336	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000272	0.000331	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00027	0.000328	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000261	0.000317	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000259	0.000314	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000253	0.000307	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000249	0.000302	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000247	0.000299	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000241	0.000293	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00024	0.000291	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000232	0.000282	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000221	0.000269	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000215	0.000261	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000214	0.000259	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000214	0.000259	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000214	0.000259	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000211	0.000256	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00021	0.000255	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000207	0.000252	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000198	0.00024	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000197	0.000239	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000196	0.000238	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000195	0.000237	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000195	0.000237	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000189	0.000229	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000171	0.000207	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000168	0.000204	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000167	0.000202	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000167	0.000202	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000163	0.000197	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000162	0.000196	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00016	0.000194	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000129	0.000157	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000129	0.000156	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00012	0.000145	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	0.000103	0.000126	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	9.23e-05	0.000112	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	8.49e-05	0.000103	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	8.42e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	7.2e-05	8.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	5.55e-05	6.74e-05	CbGpPWpGaD
